Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

BioSig Technologies, Inc. (BSGM)

0.5141   -0.02 (-3.69%) 09-27 09:59
Open: 0.5211 Pre. Close: 0.5338
High: 0.5567 Low: 0.514
Volume: 31,036 Market Cap: 40(M)

Technical analysis

as of: 2023-09-27 9:45:10 AM
Short-term rate:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Mid-term rate:       
Target: Six months: 0.8     One year: 0.93
Support: Support1: 0.51    Support2: 0.4
Resistance: Resistance1: 0.68    Resistance2: 0.8
Pivot: 0.5
Moving Average: MA(5): 0.57     MA(20): 0.51
MA(100): 0.97     MA(250): 0.87
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 53.1     %D(3): 63
RSI: RSI(14): 48.9
52-week: High: 1.64  Low: 0.25
Average Vol(K): 3-Month: 794 (K)  10-Days: 232 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ BSGM ] has closed below upper band by 28.2%. Bollinger Bands are 21.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.58 - 0.58 0.58 - 0.59
Low: 0.53 - 0.53 0.53 - 0.53
Close: 0.53 - 0.53 0.53 - 0.54

Company Description

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Headline News

Wed, 30 Aug 2023
The Cooper Companies (COO) Q3 Earnings Match Estimates - Nasdaq

Thu, 24 Aug 2023
BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals - Yahoo Finance

Thu, 20 Jul 2023
BioSig picked for NVIDIA-backed Inception program for AI - Seeking Alpha

Thu, 20 Jul 2023
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals - Yahoo Finance

Wed, 12 Jul 2023
Artificial Intelligence In Healthcare: A Potentially Strong Opportunity For BioSig Technologies (NASDAQ: - Benzinga

Thu, 29 Jun 2023
BioSig Joins Webull Corporate Connect - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 0 (M)
Shares Float 77 (M)
% Held by Insiders 6.308e+007 (%)
% Held by Institutions 17.4 (%)
Shares Short 2,560 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -3.143e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -11
Return on Assets (ttm) 555.6
Return on Equity (ttm) -291.3
Qtrly Rev. Growth 275000
Gross Profit (p.s.) 0
Sales Per Share -625.81
EBITDA (p.s.) 0
Qtrly Earnings Growth -0.7
Operating Cash Flow 0 (M)
Levered Free Cash Flow -20 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 2.56e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.